Skip to main content

Alpha Wave Global — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

93
Companies
$5.6B
Total invested
$60.1M
Avg. check
57
Industries
Biotechnology 10Pharmaceutical 6Therapeutics 6Artificial Intelligence (AI) 5Life Science 4Health Care 4+51 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 93
Moonwalk Biosciences
September 2026

Moonwalk Biosciences operates a genomic medicine company that aims to provide a new class of precision epigenetic medications.

Artificial Intelligence (AI) · San Francisco$70.0M Series B
HiBob
September 2026

HiBob is a people management platform that offers benefits administration, payroll, and employee engagement solutions.

Human Resources · New York$166.0M Private Equity
AdvanCell
July 2026

AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.

Biotechnology · Sydney$315.0M Series D
Allotera Therapeutics
July 2026

Allotera Therapeutics is developing off-the-shelf cellular therapies targeting solid tumors and hematologic malignancies

Biotechnology · St Louis$35.0M Series C
Cour Pharmaceuticals Development
June 2026

Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.

Biotechnology · Skokie$50.0M Series B
Apnimed
April 2026

Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.

Health Care · Cambridge$50.0M Debt Financing
Beast Industries
January 2026

Mr. Beast is a media production that entertains the world and helps make it a better place.

Content Creators · Greenville$200.0M Corporate Round
AtaiBeckley
October 2025

AtaiBeckley develops innovative mental health treatments that address significant unmet medical needs.

Biotechnology · Berlin$149.5M Post-IPO Equity
Amylyx Pharmaceuticals
September 2025

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

Biotechnology · Cambridge$175.0M Post-IPO Equity
WizCommerce
August 2025

WizCommerce is a B2B commerce platform for wholesale distributors.

Apps · Dover$8.0M Series A
Tavily
August 2025

Tavily is a search engine for LLMs and RAG that connects AI agents to the real-time web.

Artificial Intelligence (AI) · New York$20.0M Series A
Mitra Chem
March 2025

Mitra Chem is a lithium-ion battery material manufacturing company that innovates and commercializes iron-based cathode materials.

Battery · Mountain View$15.6M Series B
Biolinq
March 2025

Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.

Biotechnology · San Diego$100.0M Series C
ZEDEDA
January 2025

ZEDEDA is a provider of distributed orchestration and virtualization software for Edge AI Compute.

Artificial Intelligence (AI) · San JoseVenture - Series Unknown
PolyTrade
January 2025

PolyTrade operates as a blockchain-based trade finance platform.

Blockchain · Singapore$1.2M Seed
Transcend Therapeutics
October 2024

Transcend Therapeutics is a biotechnology company that offers treatments for neuropsychiatric diseases, particularly PTSD.

Biotechnology · WalthamConvertible Note
Mstack Chemicals
October 2024

A B2B platform connecting global companies for cost-effective chemical sourcing.

Houston$40.0M Series A
LENZ Therapeutics
July 2024

LENZ Therapeutics operates as an organization engaged in the late-stage clinical development of pharmaceuticals for the eyes.

Health Care · Del Mar$30.0M Post-IPO Equity
Getir
June 2024

Getir is a technology company that provides on-demand delivery services of groceries for local customers.

Consumer · Besiktas$250.0M Series G
Marea Therapeutics
June 2024

Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.

Biotechnology · San Francisco$190.0M Series B
gamma
February 2024

gamma operates as a modern media and music company.

Media and Entertainment · Los Angeles$100.0M Private Equity
HI-Bio
January 2024

Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.

Biotechnology · South San Francisco$95.0M Series B
VideoVerse
December 2023

Revolutionising video content creation & distribution through AI

Artificial Intelligence (AI) · Los AngelesSeries C
Intract
December 2023

Intract is the developer of a web3 platform for marketing services that features data-backed strategies.

Analytics · Singapore$3.0M Seed

Where Alpha Wave Global invests

Biotechnology10
Pharmaceutical6
Therapeutics6
Artificial Intelligence (AI)5
Life Science4
Health Care4

About Alpha Wave Global's portfolio

How many companies has Alpha Wave Global invested in?▸

Alpha Wave Global has invested in 93 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Alpha Wave Global invest in?▸

Alpha Wave Global's top investment sectors include Biotechnology, Pharmaceutical, Therapeutics, Artificial Intelligence (AI), Life Science. The firm invests across 57 different industry categories.

What is Alpha Wave Global's largest investment?▸

Among tracked funding rounds, AdvanCell received $315.0M in a Series D round. Alpha Wave Global's total known invested capital is $5.6B.

What is the average investment size for Alpha Wave Global?▸

Alpha Wave Global's average investment size is $60.1M across its portfolio of 93 companies.

What are Alpha Wave Global's most recent investments?▸

Recent Alpha Wave Global portfolio additions include Moonwalk Biosciences, HiBob, AdvanCell, Allotera Therapeutics, Cour Pharmaceuticals Development. These companies were founded in 2020 or later.

Reach the founders behind these 93 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →